Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention

News Daily News

Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention

August 25, 2025

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

News Daily News

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

July 14, 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

April 28, 2025

November 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

November 26, 2024

Schoolwide Intervention May Improve Obesity Outcomes Over Time

News Daily News

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Yael L. Maxwell

July 29, 2024

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

News Conference News ACC 2024

Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock

April 07, 2024

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

December 12, 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

November 11, 2023

FDA Grants Tirzepatide a New Indication for Obesity Management

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

November 08, 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

October 11, 2023

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

October 06, 2023

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

News Daily News

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

August 01, 2023

Total Meals, Not Timing, Drives Long-term Body Weight Changes

News Daily News

Total Meals, Not Timing, Drives Long-term Body Weight Changes

January 24, 2023

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

News Daily News

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Yael L. Maxwell

July 15, 2022

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

News Daily News

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

March 17, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.